Cefotaxime Multichem New Zealand - English - Medsafe (Medicines Safety Authority)

cefotaxime multichem

multichem nz limited - cefotaxime sodium 1.076 g equivalent to cefotaxime 1 g;   - powder for injection - 1 g - active: cefotaxime sodium 1.076 g equivalent to cefotaxime 1 g  

Cefotaxime Noridem 0.5 g inj./inf. sol. (pwdr.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

cefotaxime noridem 0.5 g inj./inf. sol. (pwdr.) i.v. vial

noridem enterprises ltd. - cefotaxime sodium 524 mg - eq. cefotaxime 500 mg - powder for solution for injection/infusion - 0,5 g - cefotaxime sodium 524 mg - cefotaxime

Cefotaxime Noridem 1 g inj./inf. sol. (pwdr.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

cefotaxime noridem 1 g inj./inf. sol. (pwdr.) i.v. vial

noridem enterprises ltd. - cefotaxime sodium 1,048 g - eq. cefotaxime 1 g - powder for solution for injection/infusion - 1 g - cefotaxime sodium 1.048 g - cefotaxime

Cefotaxime Noridem 2 g inj./inf. sol. (pwdr.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

cefotaxime noridem 2 g inj./inf. sol. (pwdr.) i.v. vial

noridem enterprises ltd. - cefotaxime sodium 2,096 g - eq. cefotaxime sodium 2 g - powder for solution for injection/infusion - 2 g - cefotaxime sodium 2.096 g - cefotaxime

CEFOTAXIME MEDO 1 GR Israel - English - Ministry of Health

cefotaxime medo 1 gr

a.l. medi-market ltd. - cefotaxime as sodium - powder for solution for inj/inf - cefotaxime as sodium 1 g/vial - cefotaxime - imetoxim 1 gr is indicated in the treatment of the following infections either before the infecting organism has been identified or when caused by bacteria of established sensitivity. septicaemiasrespiratory tract infections such as acute and chronic bronchitis, bacterial pneumonia, infected bronchiectasis, lung abscess and post-operative chest infections. urinary tract infections such as acute and chronic pyelonephritis, cystitis and asymptomatic bacteriuria. soft-tissue infections such as cellulitis, peritonitis and wound infections. bone and joint infections such as osteomyelitis, septic arthritis. obstetric and gynaecological infections such as pelvic inflammatory disease. gonorrhoea particularly when penicillin has failed or is unsuitable. other bacterial infections such as meningitis and other sensitive infections suitable for parenteral antibiotic therapy prophylaxis: prophylaxis of infections in patients with reduced resistance. pre-operative prophylaxis in patients who are at increased risk from infection.

Cefotaxime-Fresenius 0,5 g Namibia - English - Namibia Medicines Regulatory Council

cefotaxime-fresenius 0,5 g

bodene (pty) ltd - cefotaxime sodium equiv. to cefotaxime - powder for injection - each vial contains cefotaxime sodium equiv. to cefotaxime 500 mg

Cefotaxime-Fresenius 1,0 g Namibia - English - Namibia Medicines Regulatory Council

cefotaxime-fresenius 1,0 g

bodene (pty) ltd - cefotaxime sodium equiv. to cefotaxime - powder for injection - each vial contains cefotaxime sodium equiv. to cefotaxime 1000mg

Cefotaxime-Fresenius 2,0 g Namibia - English - Namibia Medicines Regulatory Council

cefotaxime-fresenius 2,0 g

bodene (pty) ltd - cefotaxime sodium equiv. to cefotaxime - powder for injection - each vial contains cefotaxime sodium equiv. to cefotaxime 2,0 g